格雷夫斯病的亚临床眼部变化:FUMO评分,一种用于预测格雷夫斯轨道病变进展的新工具
Giulia Lanzolla1, Francesca Saba1, Silvia Corrias1
1Department of Medical Sciences and Public Health, Endocrinology Unit, University of Cagliari and University Hospital of Cagliari, 09100 Cagliari, Italy.
The Journal of clinical endocrinology and metabolism
|February 2, 2026
概括
一个新的FUMO评分可以有效地预测Graves'轨道病 (GO) 在Graves'病 (GD) 患者中. 这种风险分层工具有助于识别可能出现明显GO的个体,从而允许早期干预.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 格雷夫斯病 (GD) 患者有发展格雷夫斯轨道病 (GO) 的风险.
- 早期预测GO发作对于及时管理至关重要.
- 新的评分系统可以改善GO的风险分层.
研究的目的:
- 评估一种新的功能和形态 (FUMO) 风险评分的预测准确性,用于在GD患者中公开的GO.
- 评估FUMO评分能够识别患有GO风险的患者的能力.
- 为了确定FUMO评分在分层GO风险中的实用性.
主要方法:
- 156名没有GO的GD患者和45名对照患者接受了基线眼科评估 (视觉功能测试,轨道超声波).
- 从视觉功能和超声波结果中得出FUMO评分 (0-8分).
- 对患者进行了24个月的随访,以评估GO的发生,活性和严重程度.
主要成果:
- 根据FUMO评分,患者被分为低风险 (0-2) 和中高风险 (3-8) 组.
- 中高风险患者有较高的明显GO发病率,活动和严重程度增加.
- 甲状腺素受体抗体 (TRAb) 水平和FUMO得分是GO的强有力的独立预测因素.
结论:
- 通过FUMO得分测量的亚临床眼部变化预测了GD患者的GO进展.
- 结合TRAb和FT3水平的FUMO评分,可靠地识别出患有明显GO风险的患者.
- FUMO评分支持在GD患者中对GO的早期风险分层.
相关概念视频
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Graves' Disease I: Introduction
52
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
52
01:24Graves Disease II: Pathophysiology
59
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
59